The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Genetic Syndromes of Severe Insulin Resistance
Open accessAbstract
Insulin resistance is among the most prevalent endocrine derangements in the world, and it is closely associated with major diseases of global reach including diabetes mellitus, atherosclerosis, nonalcoholic fatty liver disease, and ovulatory dysfunction.It is most commonly found in those with obesity but may also occur in an unusually severe form in rare patients with monogenic defects.Such patients may loosely be grouped into those with primary disorders of insulin signaling and those with defects in adipose tissue development or function (lipodystrophy).The severe insulin resistance of both subgroups puts patients at risk of accelerated complications and poses severe challenges in clinical management.However, the clinical disorders produced by different genetic defects are often biochemically and clinically distinct and are associated with distinct risks of complications.This means that optimal management of affected patients should take into account the specific natural history of each condition.In clinical practice, they are often underdiagnosed, however, with low rates of identification of the underlying genetic defect, a problem compounded by confusing and overlapping nomenclature and classification.We now review recent developments in understanding of genetic forms of severe insulin resistance and/or lipodystrophy and suggest a revised classification based on growing knowledge of the underlying pathophysiology.(Endocrine Reviews 32: 498 -514, 2011) I. Introduction II.Definition and Prevalence of Severe IR III.Generic Clinical Features of Severe IR A. Abnormal glucose homeostasis B. Ovarian dysfunction C. Acanthosis nigricans IV.Clinical Features Limited to Some Severe IR Subtypes A. Dyslipidemia and hepatic steatosis B. Abnormal adipose development or topography C. Growth disorders V. Sexual Dimorphism in Severe IR VI. Biochemical Subphenotyping of Severe IR VII.Monogenic IR Classification/Nomenclature VIII.The INSR Spectrum IX.Downstream Insulin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Congenital leptin deficiency is associated with severe early-onset obesity in humans
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., et al. (1997) · Nature · doi:10.1038/43185 · Cited by 2,936
Self-citationA mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L. M., Dull, T. J., Gray, A., Coussens, L., Liao, Y.-C., Tsubokawa, M., et al. (1985) · Nature · doi:10.1038/313756a0 · Cited by 2,251
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene
Farooqi, I. S., Keogh, J. M., Yeo, G. S. H., Lank, E. J., Cheetham, T., & O'Rahilly, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022050 · Cited by 1,778
Self-citationKrude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., & Grüters, A. (1998) · Nature Genetics · doi:10.1038/509 · Cited by 1,733
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,336
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265
Leptin-Replacement Therapy for Lipodystrophy
Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012437 · Cited by 1,247
The Syndromes of Insulin Resistance and Acanthosis Nigricans: Insulin-Receptor Disorders in Man
Kahn, C. R., Flier, J. S., Bar, R. S., Archer, J. A., Gorden, P., Martin, M. M., & Roth, J. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604012941401 · Cited by 1,106
Self-citationRajaram, S., Baylink, D. J., & Mohan, S. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0321 · Cited by 1,097
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965
Acquired and Inherited Lipodystrophies
Garg, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra025261 · Cited by 941
Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., & Vigneri, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3278 · Cited by 902
Role of Caveolae and Caveolins in Health and Disease
Cohen, A. W., Hnasko, R., Schubert, W., & Lisanti, M. P. (2004) · Physiological Reviews · doi:10.1152/physrev.00046.2003 · Cited by 893
The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Utzschneider, K. M., & Kahn, S. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0587 · Cited by 856
SHIMOMURA, I. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00009-5 · Cited by 855
Body Mass Index and the Prevalence of Hypertension and Dyslipidemia
Brown, C. D., Higgins, M., Donato, K. A., Rohde, F. C., Garrison, R., Obarzanek, E., Ernst, N. D., & Horan, M. (2000) · Obesity Research · doi:10.1038/oby.2000.79 · Cited by 851
PPAR and human metabolic disease
Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 827
Self-citationThe Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 818
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
Petersen, K. F., Oral, E. A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G. W., DePaoli, A. M., Taylor, S. I., Gorden, P., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215001 · Cited by 800
Savkur, R. S., Philips, A. V., & Cooper, T. A. (2001) · Nature Genetics · doi:10.1038/ng704 · Cited by 795
Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13
Magré, J., Delépine, M., Khallouf, E., Gedde-Dahl, T., Van Maldergem, L., Sobel, E., Papp, J., Meier, M., Mégarbané, A., BSCL Working Group, et al. (2001) · Nature Genetics · doi:10.1038/ng585 · Cited by 756
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
Li, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733
LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
Shackleton, S., Lloyd, D. J., Jackson, S. N. J., Evans, R., Niermeijer, M. F., Singh, B. M., Schmidt, H., Brabant, G., Kumar, S., Durrington, P. N., et al. (2000) · Nature Genetics · doi:10.1038/72807 · Cited by 704
Self-citationCao, H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.1.109 · Cited by 662
Szymanski, K. M., Binns, D., Bartz, R., Grishin, N. V., Li, W.-P., Agarwal, A. K., Garg, A., Anderson, R. G. W., & Goodman, J. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704154104 · Cited by 628
Large, rare chromosomal deletions associated with severe early-onset obesity
Bochukova, E. G., Huang, N., Keogh, J., Henning, E., Purmann, C., Blaszczyk, K., Saeed, S., Hamilton-Shield, J., Clayton-Smith, J., O’Rahilly, S., et al. (2010) · Nature · doi:10.1038/nature08689 · Cited by 613
Self-citationMutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
Minetti, C., Sotgia, F., Bruno, C., Scartezzini, P., Broda, P., Bado, M., Masetti, E., Mazzocco, M., Egeo, A., Donati, M. A., et al. (1998) · Nature Genetics · doi:10.1038/ng0498-365 · Cited by 598
Components of the “Metabolic Syndrome” and Incidence of Type 2 Diabetes
Hanson, R. L., Imperatore, G., Bennett, P. H., & Knowler, W. C. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3120 · Cited by 590
A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in AKT2
George, S., Rochford, J. J., Wolfrum, C., Gray, S. L., Schinner, S., Wilson, J. C., Soos, M. A., Murgatroyd, P. R., Williams, R. M., Acerini, C. L., et al. (2004) · Science · doi:10.1126/science.1096706 · Cited by 559
Self-citationThe Cardinal Manifestations of Bardet–Biedl Syndrome, a Form of Laurence–Moon–Biedl Syndrome
Green, J. S., Parfrey, P. S., Harnett, J. D., Farid, N. R., Cramer, B. C., Johnson, G., Heath, O., McManamon, P. J., O'Leary, E., & Pryse-Phillips, W. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910123211503 · Cited by 555
AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34
Agarwal, A. K., Arioglu, E., de Almeida, S., Akkoc, N., Taylor, S. I., Bowcock, A. M., Barnes, R. I., & Garg, A. (2002) · Nature Genetics · doi:10.1038/ng880 · Cited by 523
mTOR Complex1–S6K1 signaling: at the crossroads of obesity, diabetes and cancer
Dann, S. G., Selvaraj, A., & Thomas, G. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.04.002 · Cited by 481
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469
Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast
Fei, W., Shui, G., Gaeta, B., Du, X., Kuerschner, L., Li, P., Brown, A. J., Wenk, M. R., Parton, R. G., & Yang, H. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711136 · Cited by 469
Savage, D. B., Tan, G. D., Acerini, C. L., Jebb, S. A., Agostini, M., Gurnell, M., Williams, R. L., Umpleby, A. M., Thomas, E. L., Bell, J. D., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.4.910 · Cited by 430
Self-citationResnick, H. E., Jones, K., Ruotolo, G., Jain, A. K., Henderson, J., Lu, W., & Howard, B. V. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.861 · Cited by 427
Huffman, K. M., Shah, S. H., Stevens, R. D., Bain, J. R., Muehlbauer, M., Slentz, C. A., Tanner, C. J., Kuchibhatla, M., Houmard, J. A., Newgard, C. B., et al. (2009) · Diabetes Care · doi:10.2337/dc08-2075 · Cited by 410
Serum Adiponectin and Leptin Levels in Patients with Lipodystrophies
Haque, W. A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2395 · Cited by 395
Hayashi, Y. K., Matsuda, C., Ogawa, M., Goto, K., Tominaga, K., Mitsuhashi, S., Park, Y.-E., Nonaka, I., Hino-Fukuyo, N., Haginoya, K., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38660 · Cited by 394
Nishino, N., Tamori, Y., Tateya, S., Kawaguchi, T., Shibakusa, T., Mizunoya, W., Inoue, K., Kitazawa, R., Kitazawa, S., Matsuki, Y., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34090 · Cited by 392
Kim, C. A., Delépine, M., Boutet, E., El Mourabit, H., Le Lay, S., Meier, M., Nemani, M., Bridel, E., Leite, C. C., Bertola, D. R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1328 · Cited by 391
Self-citationMechanistic insights into Bardet-Biedl syndrome, a model ciliopathy
Zaghloul, N. A., & Katsanis, N. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37041 · Cited by 364
Chao, L., Marcus-Samuels, B., Mason, M. M., Moitra, J., Vinson, C., Arioglu, E., Gavrilova, O., & Reitman, M. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11245 · Cited by 356
Deletion of Cavin/PTRF Causes Global Loss of Caveolae, Dyslipidemia, and Glucose Intolerance
Liu, L., Brown, D., McKee, M., LeBrasseur, N. K., Yang, D., Albrecht, K. H., Ravid, K., & Pilch, P. F. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.008 · Cited by 352
Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis
Semple, R. K., Sleigh, A., Murgatroyd, P. R., Adams, C. A., Bluck, L., Jackson, S., Vottero, A., Kanabar, D., Charlton-Menys, V., Durrington, P., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37432 · Cited by 344
Self-citationKotronen, A., Juurinen, L., Tiikkainen, M., Vehkavaara, S., & Yki–Järvinen, H. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.021 · Cited by 339
Two Mutant Alleles of the Insulin Receptor Gene in a Patient with Extreme Insulin Resistance
Kadowaki, T., Bevins, C. L., Cama, A., Ojamaa, K., Marcus-Samuels, B., Kadowaki, H., Beitz, L., McKeon, C., & Taylor, S. I. (1988) · Science · doi:10.1126/science.2834824 · Cited by 309
Association of Bioavailable, Free, and Total Testosterone With Insulin Resistance
Tsai, E. C., Matsumoto, A. M., Fujimoto, W. Y., & Boyko, E. J. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.861 · Cited by 307
Rubio‐Cabezas, O., Puri, V., Murano, I., Saudek, V., Semple, R. K., Dash, S., Hyden, C. S. S., Bottomley, W., Vigouroux, C., Magré, J., et al. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900037 · Cited by 298
Self-citationBarbieri, R. L., & Ryan, K. J. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90091-1 · Cited by 294
Misra, A., Peethambaram, A., & Garg, A. (2004) · Medicine · doi:10.1097/01.md.0000111061.69212.59 · Cited by 285
Okada, T., Liew, C. W., Hu, J., Hinault, C., Michael, M. D., Kr̈tzfeldt, J., Yin, C., Holzenberger, M., Stoffel, M., & Kulkarni, R. N. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608703104 · Cited by 284
The Complement Abnormalities of Lipodystrophy
Sissons, J. G. P., West, R. J., Fallows, J., Williams, D. G., Boucher, B. J., Amos, N., & Peters, D. K. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602262940902 · Cited by 272
Population-Based Incidence Rates and Risk Factors for Type 2 Diabetes in White Individuals
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Meigs, J. B., Bonadonna, R. C., & Muggeo, M. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1782 · Cited by 270
Agarwal, A. K., & Garg, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8290 · Cited by 268
Toh, S. Y., Gong, J., Du, G., Li, J. Z., Yang, S., Ye, J., Yao, H., Zhang, Y., Xue, B., Li, Q., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002890 · Cited by 267
Musso, C., Cochran, E., Moran, S. A., Skarulis, M. C., Oral, E. A., Taylor, S., & Gorden, P. (2004) · Medicine · doi:10.1097/01.md.0000133625.73570.54 · Cited by 264
Self-citationPPARG F388L, a Transactivation-Deficient Mutant, in Familial Partial Lipodystrophy
Hegele, R. A., Cao, H., Frankowski, C., Mathews, S. T., & Leff, T. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3586 · Cited by 264
Insulin-Resistant Diabetes Due to a Point Mutation That Prevents Insulin Proreceptor Processing
Yoshimasa, Y., Seino, S., Whittaker, J., Kakehi, T., Kosaki, A., Kuzuya, H., Imura, H., Bell, G. I., & Steiner, D. F. (1988) · Science · doi:10.1126/science.3283938 · Cited by 254
Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy
Van Maldergem, L., Magré, J., Khallouf, T. E., Gedde-Dahl, T., Delépine, M., Trygstad, O., Seemanova, E., Stephenson, T., Albott, C. S., Bonnici, F., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.10.722 · Cited by 250
Self-citationMisra, A., & Garg, A. (2003) · Medicine · doi:10.1097/00005792-200303000-00007 · Cited by 241
Rajab, A., Straub, V., McCann, L. J., Seelow, D., Varon, R., Barresi, R., Schulze, A., Lucke, B., Lützkendorf, S., Karbasiyan, M., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000874 · Cited by 236
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy†
Javor, E. D., Ghany, M. G., Cochran, E. K., Oral, E. A., DePaoli, A. M., Premkumar, A., Kleiner, D. E., & Gorden, P. (2005) · Hepatology · doi:10.1002/hep.20672 · Cited by 228
Self-citationARIOGLU, E., ANDEWELT, A., DIABO, C., BELL, M., TAYLOR, S. I., & GORDEN, P. (2002) · Medicine · doi:10.1097/00005792-200203000-00001 · Cited by 223
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice
Foti, D., Chiefari, E., Fedele, M., Iuliano, R., Brunetti, L., Paonessa, F., Manfioletti, G., Barbetti, F., Brunetti, A., Croce, C. M., et al. (2005) · Nature Medicine · doi:10.1038/nm1254 · Cited by 219
The Human Lipodystrophy Gene BSCL2/Seipin May Be Essential for Normal Adipocyte Differentiation
Payne, V. A., Grimsey, N., Tuthill, A., Virtue, S., Gray, S. L., Dalla Nora, E., Semple, R. K., O'Rahilly, S., & Rochford, J. J. (2008) · Diabetes · doi:10.2337/db08-0184 · Cited by 199
Self-citationReceptors, Antireceptor Antibodies and Mechanisms of Insulin Resistance
Bleich, H. L., Boro, E. S., Flier, J. S., Kahn, C. R., & Roth, J. (1979) · New England Journal of Medicine · doi:10.1056/nejm197902223000808 · Cited by 194
Donohue, W. L., & Uchida, I. (1954) · The Journal of Pediatrics · doi:10.1016/s0022-3476(54)80113-2 · Cited by 192
Garg, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1776 · Cited by 189
Newgard, C. B., Brady, M. J., O'Doherty, R. M., & Saltiel, A. R. (2000) · Diabetes · doi:10.2337/diabetes.49.12.1967 · Cited by 189
Fat-specific Protein 27 Regulates Storage of Triacylglycerol
Keller, P., Petrie, J. T., De Rose, P., Gerin, I., Wright, W. S., Chiang, S.-H., Nielsen, A. R., Fischer, C. P., Pedersen, B. K., & MacDougald, O. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708323200 · Cited by 187
Lipodystrophies: disorders of adipose tissue biology.
Garg, A., & Agarwal, A. K. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.12.014 · Cited by 184
Non-DNA binding, dominant-negative, human PPARγ mutations cause lipodystrophic insulin resistance
Agostini, M., Schoenmakers, E., Mitchell, C., Szatmari, I., Savage, D., Smith, A., Rajanayagam, O., Semple, R., Luan, J., Bath, L., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.09.003 · Cited by 182
Self-citationEfficacy of leptin therapy in the different forms of human lipodystrophy
Chong, A. Y., Lupsa, B. C., Cochran, E. K., & Gorden, P. (2010) · Diabetologia · doi:10.1007/s00125-009-1502-9 · Cited by 177
Self-citationGenes, growth factors and acanthosis nigricans
Torley, D., Bellus, G. A., & Munro, C. S. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.05150.x · Cited by 173
Suzuki, Y., Lannér, C., Kim, J., Vilardo, P. G., Zhang, H., Yang, J., Cooper, L. D., Steele, M., Kennedy, A., Bock, C. B., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.8.2683-2694.2001 · Cited by 172
Insulin resistance and cancer: Epidemiological evidence
Tsugane, S., & Inoue, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01521.x · Cited by 169
Acanthosis Nigricans Associated with Insulin Resistance: Pathophysiology and Management
Hermanns-L??, T., Scheen, A., & Pi??rard, G. E. (2004) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200405030-00008 · Cited by 165
Kang, H. W., Kim, D., Kim, H. J., Kim, C. H., Kim, Y. S., Park, M. J., Kim, J. S., Cho, S., Sung, M.-W., Jung, H. C., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.541 · Cited by 163
Skarulis, M. C., Celi, F. S., Mueller, E., Zemskova, M., Malek, R., Hugendubler, L., Cochran, C., Solomon, J., Chen, C., & Gorden, P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0543 · Cited by 161
Self-citationDigenic inheritance of severe insulin resistance in a human pedigree
Savage, D. B., Agostini, M., Barroso, I., Gurnell, M., Luan, J., Meirhaeghe, A., Harding, A.-H., Ihrke, G., Rajanayagam, O., Soos, M. A., et al. (2002) · Nature Genetics · doi:10.1038/ng926 · Cited by 159
Self-citationLocalization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21–22
Peters, J. M., Barnes, R., Bennett, L., Gitomer, W. M., Bowcock, A. M., & Garg, A. (1998) · Nature Genetics · doi:10.1038/ng0398-292 · Cited by 158
Trial of Insulinlike Growth Factor I Therapy for Patients With Extreme Insulin Resistance Syndromes
Kuzuya, H., Matsuura∥, N., Sakamoto, M., Makino, H., Sakamoto, Y., Kadowaki, T., Suzuki, Y., Kobayashi, M., Akazawa, Y., Nomura, M., et al. (1993) · Diabetes · doi:10.2337/diab.42.5.696 · Cited by 157
mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis
Laplante, M., & Sabatini, D. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000323107 · Cited by 152
Mills, G. W., Lévy, J., Sampson, M., Walker, M., Avery, P. J., Hitman, G. A., Hattersley, A. T., & McCarthy, M. I. (2004) · Diabetologia · doi:10.1007/s00125-004-1338-2 · Cited by 151
Boutet, E., Mourabit, H. E., Prot, M., Nemani, M., Khallouf, E., Colard, O., Maurice, M., Durand‐Schneider, A., Chrétien, Y., Grès, S., et al. (2009) · Biochimie · doi:10.1016/j.biochi.2009.01.011 · Cited by 150
Elevated Plasma Adiponectin in Humans with Genetically Defective Insulin Receptors
Semple, R. K., Soos, M. A., Luan, J., Mitchell, C., Wilson, J. C., Gurnell, M., Cochran, E. K., Görden, P., Chatterjee, K., Wareham, N. J., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0166 · Cited by 144
Self-citationHegele, R. A., JOY, T. R., Al-Attar, S. A., & Rutt, B. K. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r700004-jlr200 · Cited by 141
The Use of U-500 in Patients With Extreme Insulin Resistance
Cochran, E. K., Musso, C., & Görden, P. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1240 · Cited by 138
Self-citationHypoadiponectinemia—Cause or Consequence of Human “Insulin Resistance”?
Cook, J. R., & Semple, R. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2286 · Cited by 135
Self-citationShastry, S., Delgado, M., Dirik, E., Turkmen, M., Agarwal, A. K., & Garg, A. (2010) · American Journal of Medical Genetics. Part A · doi:10.1002/ajmg.a.33578 · Cited by 134
Sm, R., & Mendenhall, E. N. (1956) · American Journal of Clinical Pathology · doi:10.1093/ajcp/26.3.283 · Cited by 133
Højlund, K., Hansen, T., Lajer, M., Henriksen, J. E., Levin, K., Lindholm, J., Pedersen, O., & Beck-Nielsen, H. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1592 · Cited by 130
An Unusual Form of Diabetes Mellitus in Ataxia Telangiectasia
Schalch, P., McFarlin, D. E., & Barlow, M. H. (1970) · New England Journal of Medicine · doi:10.1056/nejm197006182822503 · Cited by 128
Kaltsas, G., Isidori, A. M., Kola, B., Skelly, R. H., Chew, S. L., Jenkins, P. J., Monson, J. P., Grossman, A. B., & BESSER, G. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020922 · Cited by 126
Kaltsas, G., Mukherjee, J. J., Kola, B., Isidori, A. M., Hanson, J. A., Dacie, J. E., Reznek, R. H., Monson, J. P., & Grossman, A. B. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01792.x · Cited by 124
Blouin, C. M., Lay, S. L., Eberl, A., Köfeler, H. C., Guerrera, I. C., Klein, C., Lièpvre, X. L., Lasnier, F., Bourron, O., Gautier, J., et al. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m001016 · Cited by 122
Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance
Savage, D. B., & Semple, R. K. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833b7782 · Cited by 121
Self-citationLaminopathies: Multisystem dystrophy syndromes
Jacob, K. N., & Garg, A. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.10.018 · Cited by 118
Souren, N. Y., Paulussen, A. D. C., Loos, R. J. F., Gielen, M., Beunen, G. P., Fagard, R. H., Derom, C. A., VLIETINCK, R. F., & Zeegers, M. P. (2007) · Diabetologia · doi:10.1007/s00125-007-0784-z · Cited by 116
Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus
Grinspoon, S. K. (2005) · The American Journal of Medicine Supplements · doi:10.1016/j.amjmed.2005.01.047 · Cited by 111
Human Lipodystrophies: Genetic and Acquired Diseases of Adipose Tissue
Capeau, J., Magré, J., Caron, M., Lagathu, C., Antoine, B., Béréziat, V., Lascols, O., Bastard, J., & Vigouroux, C. (2010) · Endocrine development · doi:10.1159/000316893 · Cited by 110
Semple, R. K., Halberg, N., Burling, K., Soos, M. A., Schraw, T., Luan, J., Cochran, E. K., Dunger, D. B., Wareham, N. J., Scherer, P. E., et al. (2007) · Diabetes · doi:10.2337/db06-1665 · Cited by 110
Self-citationDash, S., Sano, H., Rochford, J. J., Semple, R. K., Yeo, G. S. H., Hyden, C. S. S., Soos, M. A., Clark, J., Rodin, A., Langenberg, C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900909106 · Cited by 106
Self-citationFreeman, M. S., Mansfield, M. W., Barrett, J. H., & Grant, P. J. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00843.x · Cited by 101
Plasma Adiponectin as a Marker of Insulin Receptor Dysfunction
Semple, R. K., Cochran, E. K., Soos, M. A., Burling, K., Savage, D. B., Görden, P., & O’Rahilly, S. (2008) · Diabetes Care · doi:10.2337/dc07-2194 · Cited by 100
Self-citationMinton, J. A. L., Owen, K. R., Ricketts, C. J., Crabtree, N. J., Shaikh, G., Ehtisham, S., Porter, J. R., Carey, C., Hodge, D. O., Paisey, R., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2633 · Cited by 98
Fertility and Obstetrical Complications in Women withLMNA-Related Familial Partial Lipodystrophy
Vantyghem, M., Vincent-Desplanques, D., Defrance-Faivre, F., Capeau, J., Fermon, C., Valat, A. S., Lascols, O., Hécart, A. C., Pigny, P., Delemer, B., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2521 · Cited by 98
Dunaif, A. E., Hoffman, A. R., Scully, R. E., Flier, J. S., Longcope, C., Levy, L. J., & Crowley, W. F. (1985) · PubMed · Cited by 94
Dissecting the role of insulin resistance in the metabolic syndrome
Haas, J. T., & Biddinger, S. B. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832b2024 · Cited by 91
Beltrand, J., Beregszàszi, M., Chevenne, D., Sebag, G. H., de Kerdanet, M., Huet, F., Polak, M., Tubiana‐Rufi, N., Lacombe, D., Paoli, A. M. D., et al. (2007) · PEDIATRICS · doi:10.1542/peds.2006-3165 · Cited by 89
IGF-I treatment of insulin resistance
McDonald, A. L., Williams, R. M., Regan, F. M., Semple, R. K., & Dunger, D. B. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0271 · Cited by 88
Self-citationComplement Abnormalities in Acquired Lipodystrophy Revisited
Savage, D. B., Semple, R. K., Clatworthy, M. R., Lyons, P., Morgan, B. P., Cochran, E. K., Görden, P., Raymond‐Barker, P., Murgatroyd, P. R., Adams, C., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1703 · Cited by 87
Self-citationFlier, J. S., Moller, D. E., Moses, A. C., O’Rahilly, S., Chaiken, R. L., Grigorescu, F., Elahi, D., Kahn, B. B., Weinreb, J. E., & Eastman, R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8388881 · Cited by 87
Self-citationWhole body insulin resistance in myotonic dystrophy
Moxley, R. T., Corbett, A. J., Minaker, K. L., & Rowe, J. W. (1984) · Annals of Neurology · doi:10.1002/ana.410150208 · Cited by 85
Genetic Defects in Human Pericentrin Are Associated With Severe Insulin Resistance and Diabetes
Huang‐Doran, I., Bicknell, L. S., Finucane, F. M., Rocha, N., Porter, K. M., Tung, Y. C. L., Szekeres, F. L. M., Krook, A., Nolan, J. J., O’Driscoll, M., et al. (2011) · Diabetes · doi:10.2337/db10-1334 · Cited by 84
Self-citationCochran, E., Young, J. R., Sebring, N., DePaoli, A., Oral, E. A., & Gorden, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031952 · Cited by 83
Self-citationNakae, J., Kato, M., Murashita, M. M., Shinohara, N., Tajima, T., & Fujieda, K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4602 · Cited by 77
Maddux, B. A., Chan, A., Mandarino, L. J., Goldfine, I. D., & Filippis, E. A. D. (2006) · Diabetes Care · doi:10.2337/dc05-1367 · Cited by 76
Lipid droplets: FSP27 knockout enhances their sizzle
Puri, V., & Czech, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36554 · Cited by 71
A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism
Takahashi, Y., Kadowaki, H., Momomura, K., Fukushima, Y., Orban, T., Okai, T., Taketani, Y., Akanuma, Y., Yazaki, Y., & Kadowaki, T. (1997) · Diabetologia · doi:10.1007/s001250050695 · Cited by 70
Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy
Jackson, S. N. J., Howlett, T. A., McNally, P. C., O’Rahilly, S., & Trembath, R. C. (1997) · QJM · doi:10.1093/qjmed/90.1.27 · Cited by 68
Self-citationTan, K. M. L., KIMBER, W. A., Luan, J., Soos, M. A., Semple, R. K., Wareham, N. J., O’Rahilly, S., & Barroso, I. (2007) · Diabetes · doi:10.2337/db06-0921 · Cited by 68
Self-citationSavage, D. B., Zhai, L., Balasubramanian, R., Choi, C. S., Snaar, J. E. M., McGuire, A. C., Wou, S.-E., Medina‐Gómez, G., Kim, S., Bock, C. B., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050027 · Cited by 67
Self-citationSex Hormone–Binding Globulin and Risk of Type 2 Diabetes
Stefan, N., Schick, F., & Häring, H.-U. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0910143 · Cited by 67
Evaluation of Short Stature, Carbohydrate Metabolism and Other Endocrinopathies in Bloom’s Syndrome
Díaz, A., Vogiatzi, M. G., Sanz, M. M., & GERMAN, J. L. (2006) · Hormone Research in Paediatrics · doi:10.1159/000093826 · Cited by 64
Antuna-Puente, B., Boutet, E., Vigouroux, C., Lascols, O., Slama, L., Caron, M., Khallouf, E., Lévy‐Marchal, C., Capeau, J., Bastard, J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1824 · Cited by 60
Longo, N., Singh, R., Griffin, L. D., Langley, S. D., Parks, J. S., & Elsas, L. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.3.8077364 · Cited by 58
Beltrand, J., Lahlou, N., Charpentier, T. L., Sebag, G. H., Leka, S., Polak, M., Tubiana‐Rufi, N., Lacombe, D., de Kerdanet, M., Huet, F., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-1027 · Cited by 58
Acanthosis nigricans, insulin resistance and cutaneous virilism
EARTH, J. H., Ng, L. L., WOJNAROWSKA, F. T., & Dawber, R. P. R. (1988) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1988.tb02561.x · Cited by 57
Dwianingsih, E. K., Takeshima, Y., Itoh, K., Yamauchi, Y., Awano, H., Malueka, R. G., Nishida, A., Ota, M., Yagi, M., & Matsuo, M. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.06.016 · Cited by 56
Dib, K., Whitehead, J. P., Humphreys, P. J., Soos, M. A., Baynes, K., Kumar, S., Harvey, T., & O’Rahilly, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119884 · Cited by 56
Self-citationRegan, F. M., Williams, R. M., McDonald, A. L., Umpleby, A. M., Acerini, C. L., O’Rahilly, S., Hovorka, R., Semple, R. K., & Dunger, D. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2088 · Cited by 56
Self-citationLane, W. S. (2006) · Endocrine Practice · doi:10.4158/ep.12.3.251 · Cited by 48
Zenobi, P. D., Glatz, Y., Keller, A., Graef, S., Jaeggi-Groisman, S. E., Riesen, W. F., Schoenle, E. J., & Froesch, E. R. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1310251 · Cited by 47
Greenfield, J. R., Tuthill, A., Soos, M. A., Semple, R. K., Halsall, D. J., Chaudhry, A., & O’Rahilly, S. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02621.x · Cited by 46
Self-citationHypoglycemia and Resistance to Ketoacidosis in a Subject without Functional Insulin Receptors
Ogilvy‐Stuart, A., Soos, M. A., Hands, S., Anthony, M. Y., Dunger, D. B., & O’Rahilly, S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7631 · Cited by 45
Self-citationEfficacy of pioglitazone in familial partial lipodystrophy of the Dunnigan type: a case report
Moreau, F., Boullu-Sanchis, S., Vigouroux, C., Lucescu, C., Lascols, O., Sapin, R., Ruimy, D., Guerci, B., Pinget, M., & Jeandidier, N. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.04.005 · Cited by 43
Whitehead, J. P., Humphreys, P. J., Krook, A., Jackson, R., Hayward, A. C., Lewis, H., Siddle, K., & O’Rahilly, S. (1998) · Diabetes · doi:10.2337/diabetes.47.5.837 · Cited by 39
Self-citationMurphy, R., Baptista, J., Holly, J. M. P., Umpleby, A. M., Ellard, S., Harries, L. W., Crolla, J. A., Cundy, T., & Hattersley, A. T. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0819 · Cited by 37
Baynes, K., Beeton, C. A., Panayotou, G., Stein, R. C., Soos, M. A., Hansen, T. F., Simpson, H. C. R., O’Rahilly, S., Shepherd, P. R., & Whitehead, J. P. (2000) · Diabetologia · doi:10.1007/s001250050050 · Cited by 36
Self-citationMultidrug therapy in a patient with Rabson–Mendenhall syndrome
Moreira, R. O., Zagury, R., Nascimento, T. S., & Zagury, L. (2010) · Diabetologia · doi:10.1007/s00125-010-1879-5 · Cited by 36
Clinical, Endocrine and Metabolic Aspects of the Werner Syndrome Compared with Those of Normal Aging
Imura, H., Nakao, Y., Kuzuya, H., Okamoto, M., Okamoto, M., & Yamada, K. D. (1985) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-7853-2_6 · Cited by 34
Simha, V., Rao, S., & Garg, A. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00978.x · Cited by 33
Clinical evidence that hyperinsulinaemia independent of gonadotropins stimulates ovarian growth
Musso, C., Shawker, T. H., Cochran, E. K., Javor, E. D., Young, J. R., & Görden, P. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02302.x · Cited by 33
Self-citationKoulouri, O., & Conway, G. S. (2009) · BMJ · doi:10.1136/bmj.b847 · Cited by 30
Effectiveness of Gastric Bypass Surgery in a Patient With Familial Partial Lipodystrophy
Utzschneider, K. M., & Trence, D. (2006) · Diabetes Care · doi:10.2337/dc06-0130 · Cited by 29
Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly
Kumar, S., Durrington, P. N., O’Rahilly, S., Laing, I., Humphreys, P. J., Olukoga, A. O., Bhatnagar, D., Mackness, M., Davis, J. R., & Boulton, A. J. M. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855786 · Cited by 27
Self-citationInherited lipodystrophies and the metabolic syndrome
Monajemi, H., Stroes, E. S. G., Hegele, R. A., & Fliers, E. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02906.x · Cited by 26
Yamada, K., Ikegami, H., Yoneda, H., Miki, T., & Ogihara, T. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.2094 · Cited by 23
Mantzoros, C. S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0340 · Cited by 22
Leptin therapy in lipodystrophy
Savage, D. B., & O’Rahilly, S. (2009) · Diabetologia · doi:10.1007/s00125-009-1545-y · Cited by 22
Self-citationKausch, C., Bergemann, C., Hamann, A., & Matthaei, S. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212090 · Cited by 19
Lannér, C., Suzuki, Y., Bi, C., Zhang, H., Cooper, L. D., Bowker-Kinley, M. M., & DePaoli-Roach, A. A. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2283 · Cited by 19
Central players in inherited lipodystrophies
Jeninga, E. H., & Kalkhoven, E. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.06.006 · Cited by 18
Berger, D., Barroso, I., Soos, M. A., Yeo, G. S. H., Schafer, A. J., O’Rahilly, S., & Whitehead, J. P. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00779.x · Cited by 17
Self-citationAnalysis of TBC1D4 in patients with severe insulin resistance
Dash, S., Langenberg, C., Fawcett, K. A., Semple, R. K., Romeo, S., Sharp, S. J., Sano, H., Lienhard, G. E., Rochford, J. J., Howlett, T. A., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1724-x · Cited by 15
Self-citationGeorge, S., Johansen, A. B., Soos, M. A., Mortensen, H. B., Gammeltoft, S., Saudek, V., Siddle, K., Hansen, L., & O’Rahilly, S. (2003) · Endocrinology · doi:10.1210/en.2002-220815 · Cited by 14
Self-citationSyndromes of Severe Insulin Resistance and/or Lipodystrophy
Semple, R. K., Savage, D. B., Halsall, D. J., & O’Rahilly, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374430-2.00004-3 · Cited by 14
Self-citationFalchi, M., Wilson, S. G., Paximadas, D., Swaminathan, R., & Spector, T. D. (2008) · Diabetes · doi:10.2337/db07-0708 · Cited by 11
Cited by
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms
Arcidiacono, B., Iiritano, S., Nocera, A., Possidente, K., Nevolo, M. T., Ventura, V., Foti, D., Chiefari, E., & Brunetti, A. (2012) · Experimental Diabetes Research · doi:10.1155/2012/789174 · Cited by 606
EPIC-InterAct Consortium, Lotta, L. A., Cambridge FPLD1 Consortium, Gulati, P., Day, F. R., Payne, F., Ongen, H., van de Bunt, M., Gaulton, K. J., Eicher, J. D., et al. (2017) · Nature Genetics · doi:10.1038/ng.3714 · Cited by 585
Self-citationCauses, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans
Stefan, N., Schick, F., & Häring, H.-U. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.008 · Cited by 575
Androgen insensitivity syndrome
Hughes, I. A., Davies, J. D., Bunch, T. I., Pasterski, V., Mastroyannopoulou, K., & MacDougall, J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60071-3 · Cited by 553
Metadata
- Authors
- Semple, R. K., Savage, D. B., Cochran, E. K., Gorden, P., & O'Rahilly, S.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2011-05-02
- Volume
- 32
- Issue
- 4
- Pages
- 498-514
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2059717716
- Cited by
- 358
- References
- 169
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.